Ashok Soota to invest Rs 200 crore on medical research trust SKAN for Ageing, Neurological disorders
Of this, Rs 100 crore is earmarked for partners such as St John's, Centre for Brain Research (CBR), IIT Roorkee, NIMHANS and any new partners which may be added. The remaining amount is earmarked for investments in SKAN and direct projects within SKAN, it added.;
New Delhi: IT veteran Ashok Soota has set up SKAN, a not-for-profit entity that will conduct medical research, and has committed Rs 200 crore towards the effort.
The research for the projects will be done through reputed partners, a statement said on Sunday.
Also Read: Manipal Hospitals to get Rs 2100 crore from NIIFL
The strategic partner for neurological research is the Centre for Brain Research (CBR) at Indian Institute Science-Bangalore (IISc), it added.
CBR is putting together a consortium to handle the first project on Parkinson's disease.
The strategic partner for ageing is the upcoming St. John's Geriatric Centre (SJGC), to be located on St John's Hospital campus.
"Soota has agreed to fund the setting up of the Centre for Research in Ageing and Geriatrics (CRAG) at the SJGC and to support joint projects," according to the statement.
Of this, Rs 100 crore is earmarked for partners such as St John's, Centre for Brain Research (CBR), IIT-Roorkee, NIMHANS and any new partners which may be added. The remaining amount is earmarked for investments in SKAN and direct projects within SKAN, it added.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.